WARFARIN administered to tumourbearing mice reduces the number of spontaneous lung metastases . The mechanism of this phenomenon is not yet fully understood, but we have shown that it is probably unrelated to the induced coagulopathy (Hilgard & Maat, 1979) . Administration of the drug and simultaneous restoration of the depleted coagulation factors II, VII, IX and X, still significantly lowered the numbers of lung metastases. On the other hand, a stimulatory effect of coumarin and related compounds on macrophages has been described (Piller, 1977) . Recently it has been shown that the coumarin derivative warfarin also increases in vivo macrophage activity (von Melcher & Hilgard, submitted for publication).
These data support the hypothesis that the antitumour effect of coumarin derivatives might be mediated by stimulation of the RES. To test this, it has been investigated whether substances with a blocking effect on macrophages thus inhibit the warfarin-induced reduction of tumour-colony formation in the lungs. Among those substances are the seaweed extract carrageenan (a sulphated galactan of high molecular weight) and silica. Both have a number of immuno-suppressive properties, including inactivation of macrophages (Allison et al., 1966; Ishizaka et at., 1977) . In the present study the effects of carrageenan and silica on warfarin-induced reduction of lung metastasis were investigated with 2 different tumours. Accepted 2 November 1979 Since certain effects of carrageenan on blood coagulation have been described in the literature (Anderson & Duncan, 1965 ; ) coagulation parameters were also studied.
Groups of 10-15 C57BL/Rij male mice were injected s.c. with 106 viable tumour cells (Lewis lung carcinoma or B-16 melanoma). Warfarin administration was begun on the day of tumour transplant by i.p. injection of 2-5 mg/kg, and followed by a daily oral dose in the drinking water, till the end of the experiment.
Anticoagulation was monitored by the thrombo-test assay. The dose of warfarin was selected so as to keep the thrombo-test values of the treated animals 2-5 x normal. Iota carrageenan (type V, Sigma) was given on Days 0, 5 and 10, as an i.p. injection of 0 5 mg/mouse dissolved in physiologic saline, sterilized by autoclaving for 10 min at 15 lb/in2. A regimen was chosen which was found to be effective in mice by Ishizaka et al. (1977) The levels of fibrinogen degradation products in serum of carrageenan-treated mice were not increased.
In the animals receiving carrageenan alone (Table I) there was an increase in lung metastases over the controls. The warfarin-treated mice showed the expected drop in lung metastases, but a significant increase to normal values was again seen in animals receiving carrageenan in addition to the warfarin regimen.
Silica (Table II) alone was not followed by an increase of lung metastases, but silica added to warfarin gave a significant increase in lung metastases over warfarin alone. The results of experiments with Lewis lung carcinoma did not differ from those with B-16 melanoma (Table III) . The fact that the number of metastases in the B-16 control groups is generally somewhat lower than those in the Lewis lungbearing animals is a common phenomenon, and presumably due to tumour-specific properties.
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Only recently, we have been able to show that warfarin administration to mice, followed by reconstitution of the blood clotting capacity, still significantly decreased the number of lung colonies by an amount equal to that seen after warfarin treatment alone (Hilgard & Maat, 1979) . These findings were suggestive for an explanation of the major effects in a different direction.
Since this antitumour effect was not mediated by any coagulation factor, one could question which other property of coumarin derivatives might play a role. Benzopyrones, including coumarin and warfarin, have been shown to stimulate macrophage activity. About 15 years ago Kovach et al. (1965) showed that coumarin (5-6-benzo-o-pyrone) enhanced the carbon clearance of the blood. Later Piller (1976b, c, d; 1977; and Dunn et al. (1977) found that coumarin administration enhanced phagocytosis by macrophages. The actual mechanism of this phenomenon, however, is still uncertain. It might be mediated by an increased lysis of proteins by macrophages, since in lymphoedenma the amount of accumulated protein is considerably reduced after administration of benzopyrones (CasleySmith, 1976) . Destruction of macrophages by treatment with silica completely abolishes this effect (Casley-Smith et al., 1978; Piller, 1976a) . The total number of macrophages is also increased by administration of benzopyrones, including coumarin (Piller, 1] 
978).
Recently, wvarfarin has been shown to increase in vivo thioglycollate-stimulated pinocytosis in mice (Melchner & Hilgard, submitted for publication). Neither the humoral immune response nor the T-cell activity of mice seem to be affected by warfarin (Berkarda et al., 1978) . Undoubtedly, macrophages are a major factor in the host's defence against tumour cells (Alexander, 1974) . Stimulation of this defence is likely to increase antitumour activity, as in warfarin-treated tumourbearing animals. If macrophage stimulation is the actual cause of decreased metastasis, a substance which selectively blocks macrophage activity is likely to abolish the effect.
In the present study both carrageenan and silica restore the number of metastases in warfarin-treated tumour-bearing animals to control levels. Carrageenan alone raises the number of lung metastases above the control levels, which could partially be due to immune suppression. Apart from carrageenan's selective toxicity for macrophages (Allison et al., 1966; Nelson & Nelson, 1978; Fowler & Thomson, 1978; Ishizaka et al., 1977) it has also been shown to potentiate tumour growth (Thomson & Fowler, 1977; Keller, 1976; Lotzova & Richie, 1977) . Since it has been shown to be non-cytotoxic to lymphocytes per se (Catanzaro et al., 1971 ) and does not impair T-cell responses to PHA (Lake et al., 1971) one may conclude that the actual mechanism is impairment of macrophage activity against tumour growth. This might be mediated by the carrageenaninduced release of lysosomal enzymes in macrophages.
The effect of silica is not so strong; the number of lung metastases is unchanged compared with controls. Nelson & Nelson (1978) also failed to demonstrate immunosuppressive properties of silica, or any effect on growth of tumours in mice. Yet it can reverse the warfarin-induced macrophage stimulation.
No effect of carrageenan on blood coagulation capacity could be found in this study. If carrageenan did have an anticoagulant activity, as has been described by Anderson & Duncan (1965) in rabbits after i.v. injection, this certainly would not increase the number of metastases, since heparin drastically reduces the number of lung colonies after i.v. injection of tumour cells (Maat, 1978) and has no effect on metastasis in tumourbearing animals (Maat & Hilgard, submitted for publication) . Disseminated intravascular coagulation due to carrageenan has been described by but does not seem to occur with iota-carrageenan . Any signs of disseminated intravascular coagulation, moreover, were not observed at the dose of carrageenan used in our experiments, since the serum level of fibrinogen degradation products was not increased.
In conclusion, both macrophage inhibitors silica and carrageenan abolish the warfarin-induced decrease tumour metastasis, which strongly supports the concept that the antitumour effect of coumarin derivatives is mediated by stimulation of macrophages. The results do not seem to be influenced by (any effects of carrageenan on blood-coagulation factors.
